DOGITA (DOGA) Is Now Available for Trading for LBank Exchange
- 68
Road Town, British Virgin Islands--(Newsfile Corp. - May 17, 2024) - In a significant move for cryptocurrency enthusiasts, LBank Exchange, a premier global digital asset trading platform, has announced the listing of DOGITA (DOGA) on May 17, 2024. Users of LBank Exchange can brace themselves for the DOGA/USDT trading pair, which went live already.
DOGA Listing Banner
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8831/209693_ff30ed465467aa70_001full.jpg
DOGITA (DOGA) is a feminine-inspired meme token on the Binance Smart Chain, aiming to promote diversity and gender equality in the cryptocurrency space with plans for expansion and a robust community-driven approach.
Introducing DOGITA: a female-focused meme token for crypto inclusivity
LBank Exchange is thrilled to announce the upcoming listing of DOGITA (DOGA), a new meme token that brings a feminine touch to the world of cryptocurrency. Created on the Binance Smart Chain, it aims to address the gender gap in the crypto community by promoting diversity and inclusion. With its unique approach, DOGITA not only embraces the lighthearted spirit of meme coins but also supports substantive causes related to female empowerment.
The token boasts robust features including community-driven audits, regular AMA sessions, and a comprehensive marketing strategy that leverages various digital platforms. This ensures both transparency and engagement, laying a solid foundation for growth and active community participation. Moreover, DOGITA is preparing for expansion onto the Ethereum network, promising wider accessibility and potentially greater adoption.
DOGITA is more than just a digital asset; it's a movement towards creating a more inclusive environment within the crypto space. Through strategic partnerships, ongoing development, and dedicated charity initiatives, DOGITA is set to challenge existing norms and offer a new perspective in the cryptocurrency narrative.
About DOGA Token
Based on BEP20, DOGA has a total supply of 100 billion (i.e. 100,000,000,000). DOGA's token distribution allocates 60% to the presale and the remaining funds to liquidity on decentralized exchanges. The DOGA token is poised for its debut on LBank Exchange at 12:00 UTC on May 17, 2024. Investors who are interested in DOGA can easily buy and sell on LBank Exchange now.
Learn More about DOGA Token:
Official Website: https://dogita.io/
Twitter: https://twitter.com/missdogita
Telegram: https://t.me/dogitaofficial
Contract: https://bscscan.com/token/0x05311d9aA0E17D1071986146CeD510C85c71B52f
About LBank
LBank is one of the top crypto exchanges, established in 2015. It offers specialized financial derivatives, expert asset management services, and safe crypto trading to its users. The platform holds over 9 million users from more than 210 regions across the world. LBank is a cutting-edge growing platform that ensures the integrity of users' funds and aims to contribute to the global adoption of cryptocurrencies.
Start Trading Now: lbank.com
Community & Social Media:
l Telegram
l Twitter
l LinkedIn
l YouTube
Press contact:
[email protected]
Business Contact:
LBK Blockchain Co. Limited
LBank Exchange
[email protected]
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/209693
Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
- Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
- Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
- Hyundai Motor America Reports May 2024 Sales